Ohio State Navbar

Directory

Haas, Garrie MD


Staff photo

473 W 12th Ave
Columbus, OH 43210

Phone: (614) 293-4967

Email: haas.5@osu.edu

 

Current OSU Appointments

Professor-Clinical, Cardiovascular Medicine

Physician, FGP-Cardiovascular Medicine

 

Books

Managing heart failure with transplantation, ventricular assist devices, and cardiomyoplasty

 

Licenses

1984 - present Board Certification (Diplomate): National Board of Medical Examiners
1986 - present Board Certification (Diplomate): American Board of Internal Medicine
1989 - present Board Certification (Diplomate): American Board of Internal Medicine
2010 - present Advanced Heart Failure/Transplant Cariology: American Board of Internal Medicine
- 1984 Diplomate: National Board of Medical Examiners
 

Chapters in Books

Vasodilator therapy for congestive heart failure (Non-ACE inhibition)

Cardiac transplantation, ventricular assist devices, and cardiomyoplasty in patients with advance heart failure

Adult clinical cardiology self-assessment program: 1997-1998

Acute Heart Failure Management

Post-transplant care: medical complications

Heart and Circulatory Failure

Acute Heart Failure Management

Comprehensive pharmacologic management strategies for heart failure

Acute Developmemt and decompensation of heart failure

Cardiac Resynchronization Therapy: Summary of the Large Randomized Trials.

Comprehensive pharmacologic management strategies for heart failure

Cardiology

 

Degrees

1978 B.A., Ohio Wesleyan University

1983 M.D., Marshall University

 

Editorial Activities

present Journal of American College of Cardiology
1996 - present Heart and Lung
1996 - present Cleveland Clinc Journal
2003 - present Journal Cardiac Failure
2006 - present Cardiology
2007 - present CHF Journal
2009 - present European Heart Journal
 

Honors

1987 - 1988 Fellowship. Central Ohio Heart Chapter.
1988 - 1989 Fellowship. Central Ohio Heart Chapter.
1998 - 1999 America's Best Doctors. US News & World Report.
2001 - 2002 America's Best Doctors. US News & World Report.
2002 - 2003 American Best Doctors. US News & World Report.
2003 - 2004 America's Best Doctor. US News & World Report.
2004 - 2005 American's Best Doctor. US News & World Report.
2005 - 2006 America's Best Doctors. US News & World Report.
2006 - 2007 American's Best Doctor. US News & World Report.
2007 - 2008 America's Best Doctors. U.S. News & World Report.
2008 - 2009 American's Best Doctor. US News & World Report.
2009 - 2010 Best Doctors. US News & World Report.
2010 - present Best Doctor. US News & World Report.
2010 - present Education Programs Excellence in Teaching Award. Internal Medicine Students.
2012 Best Docs in Central Ohio. Best Doctors, Inc. Published in December 2012 issue of Columbus Monthly.
 

Journal Articles

. -.

 

Reference Works

January 1985 ."" .
January 1988 Haas GJ, Carpenter J, Huss-Randolph P, Binkley PF, Leier CV."Central and regional hemodynamic responses to Flosequinan in patients with congestive heart failure" . : 821A
January 1989 Binkley PF, Shaffer PB, Haas GJ, Ryan JM, Leier CV."Phosphodiesterase inhibition modulates diastolic as well as systolic ventricular performance" . : 238 A
January 1989 Starling RC, Haas GJ, Hammer DF, Wooding-Scott M, Myerowitz PD, Cody RJ."Progressive left ventricular hypertrophy in cardiac transplant patients" . : II-537
January 1989 Leier CV, Haas GJ, Binkley PF."Flosequinan therapy in congestive heart failure." . : II-629
January 1990 Tice FD, Binkley PF, Haas GJ, Nunziata E. Cody RJ.."Use of heart rate spectral analysis to assess carotid baroreceptor response to sustained neck suction" . : 334 A
January 1990 Binkley PF, Haas G, Nelson SD, Nunziata E, Cody RJ.."Evolution of autonomic dysfunction in early stages of congestive heart failure; Demonstration in a paced dog model" . : III-724
January 1990 Haas GJ, McCune S, Brown DM, Cody RJ."Reversal of myocardial hypertrophy with ACE inhibition in a rodent model of heart failure" . : III_675
January 1990 Cody RJ, Haas GJ, Brown DM."Hemodynamic characteristics of DUP 753: An oral angiotensin II antagonist in the spontaneously hypertensive rat" . : 894 A
January 1990 Binkley PF, Nunziata E, Haas GJ, Halprin I, Brown DM, Cody RJ."Non-invasive mapping of autonomic activity in the conscious spontaneously hypertensive rat" . : III-683
January 1990 Haas GJ, Bush CA, Kolibash AJ, VanFossen DB."Coronary flow reserve does not parallel angiographic improvement 24 Hours following successful coronary angioplasty" . : 329 A
January 1990 Binkley PF, Haas GJ, Smith K, Cody RJ."The parasympathetic component of the autonomic response to upright exercise in normal subjects" . : 355A
January 1991 Cody RJ, Haas GJ, Binkley PF, Kelly R, Capers Q."Plasma endothelin correlates with the extent of pulmonary hypertension in chronic congestive heart failure patients" .
January 1991 Binkley PF, Haas GJ, Nunziata E."Augmented parasympathetic tone following angiotensin converting enzyme inhibition is independent of plasma angiotensin converting enzyme concentration: implication regarding the mechanism of modulation of autonomic tone in congestive heart failure" . : I-666
January 1991 Binkley PF, Haas GJ, Maymir JC, Brown DM, Cody RJ."Angiotensin II blockade promotes increased conduit vessel compliance in the spontaneously hypertensive rat (SHR)" . : 231 A
January 1991 Binkley PF, Haas GJ, Brown DM, Cody RJ."Pulsatile hydraulic load in the spontaneously hypertensive rat" . : 222A
January 1991 Binkley PF, Nunziata E, Haas GJ, Cody RJ."Sustained augmentation of parasympathetic tone with chronic angiotensin converting enzyme inhibition in congestive heart failure" . : 22 A
January 1991 Binkley PF, Haas GJ, Nunziata E, Tice F, Cody RJ."Abnormal parasympathetic response to baroreceptor loading in congestive heart failure: Demonstration by analysis of heart rate variability" . : 177A
January 1991 Cody RJ, Haas GJ, Brown DM."Calcium voltage channel antagonism prevents endothelin-induced hypertension" . : 202 A
January 1991 Cody RJ, Haas GJ, Binkley PF, Brown DM."Hemodynamic and vascular characteristics of DUP 753: A specific angiotensin II antagonist, in the spontaneously hypertensive rat (SHR)" . : 202A
January 1991 Binkley PF, VanFossen D, Haas GJ, Leier CV."Vascular mechanism of combination therapy with Hydralazine and Nitroglycerin: Contrasting peripheral and conduit vessel response" . : 758A
January 1992 Jarcho J, Naftel DC, Shroyer TW, Kirklin JK, Bourge RC, Barr ML, Pitts DG, Starling RC, and the Transplant Cardiologists Research Database (TCRD) Group."Does HLA mismatch affect the incidence of rejection after cardiac transplantation: A multi-institutional study" . : A-50
January 1992 Binkley PF, Khot U, Haas GJ Reeder DD, Nunziata E, Myerowitz PD, Starling RC."Preservation of beat-to-beat blood pressure variability despite abnormal heart rate variability following cardiac transplantation." . : 684A
January 1992 Miller LW, Naftel DC, Bourge RC, Kirklin JK, Brozena SC, and the Transplant Cardiologists Research Database Group.."Infection following cardiac transplantation: A multi-institutional analysis" . : II-192
January 1992 Bourge RC, Naftel DC, Con Stanzo-Nordin M, Kirklin JK, Young J, and the Transplant Cardiologists Research Database Group."Risk factors for deaths after cardiac transplantation: A multi-institutional study" . : II-191
January 1992 Boudoulas H, Starling RC,Haas GJ, Spark E, Myerowitz PD, Wooley CF.."Left atrial volume and function in orthotopic heart transplantation" . : I-770
January 1992 Binkley PF, Haas GJ, Brown D, Cody RJ."Differential vascular response to endothelin: modulation of peripheral vascular resistance but not conduit vessel compliance." . : 226A
January 1992 Haas GJ, Wooding-Scott M, Binkley PF, Myerowitz PD, Kelley R, Cody RJ.."Plasma endothelin is increased in patients following successful cardiac transplantation" . : 296 A
January 1992 Kobashigawa J, Naftel DC, Bourge RC, Kirklin JK, Ventura HO, and the Transplant Cardiologists Research Database Group.."Acute rejection after cardiac transplantation: A multi-institutional analysis." . : 11-192
January 1993 Binkley PF, Nunziata E, Khot UN, Haas GJ, Starling RC, Cody RJ."Spectral analysis of blood pressure variability in congestive heart failure: Implications for oscillatory blood pressure control in the setting of ventricular dysfunction" . : 682A
January 1993 Alton ME, Haas GJ, Brown DM, Sarrimanolis NI, Cody RJ."Echocardiographic regression of left ventricular mass in the Goldblatt hypertensive rat" . : 28A
January 1993 Cody RJ, Leier CV, Bristow MR, Fifer MA, Binkley PF, Haas GJ, Starling RC, Abraham WT, Lowers BD, Dee GW, Semigran MJ, Cowart TD."OPC 18790 Produces titratable hemodynamic benefit in hospitalized patients with severe congestive heart failure" . : I-300
January 1994 Binkley PF, VanFossen DB, Haas GJ, Cody RJ, Leier CV."Persistence of abnormal ventriculoarterial coupling and decreased conduit vessel compliance despite peripheral vasodilatation with Hydralazine and Nitroglycerin in congestive heart failure" .
January 1994 Khot UN, Starling RC, Haas GJ, Myerowitz PD."Restoration of Diurnal blood pressure variability after cardiac transplantation" . : I-540
January 1994 Binkley PF, Haas GJ, Nunziata E, Cody RJ.."Time course of angiotensin converting (ACE) inhibition induced Baroreflex sensitization in congestive heart failure: Relation to augmented vagal tone and beat-to-beat blood pressure regulation" . : I-174
January 1995 Haas GJ, Gin-Pease ME, Hunnicutt M, Alton ME, Merola AJ, Cody RJ."Chronic Hydralazine or Enalapril normalize Myosin isoforms in the spontaneously hypertensive rat, but only Enalapril normalizes left ventricular mass" .
January 1995 Rodeheffer R, Naftel D, Wamer-Stevenson L, Porter C, Young J, Miller L, Kenzora J, Haas GJ, Kirklin J, Bourge R, and the Cardiac Transplant Research Database (CTRD)."Changing patterns in recipient and donor management in cardiac transplantation" . : A-3
January 1996 Binkley PF, Nunziata E, Haas GJ, Starling RC, Cody RJ."Dissociation between parasympathetic tone and suppression of serum angiotensin converting enzyme activity in CHF" .
January 1996 Dunlap S, Starling RC, Haas GJ."Simplified assessment of pulmonary hypertension in heart transplant candidates" .
January 1996 Binkley PF, Ahmed S, Starling RC, Haas GJ, Nunziata E, Cody RJ, Leier CV."Altered autonomic balance with Carvedilol in congestive heart failure does not result from increase in Baroflex gain" .
January 1998 Park M, Young JB, Hobbs RE,Haas GJ, Goormastic M, Boparai N, Starling RC.."The use of home inotropic therapy for patients awaiting cardiac transplant: analysis of nationwide survey among U.S. cardiac transplant centers" . : 1
January 1999 James KB, Mc Carthy PM, Wolski K, Rodkey SM, Haas GJ."Cardiac Exercise Hemodynamics take after partial ventriculectomy" . : I-67
January 1999 Abraham WT, Suresh DP, Wagoner LE, Haas GJ, Mc Cord J, Rydzinski S, Nelson CB, Bakker-Arkema RG; University of Cincinnati College of Medicine, Cincinnati, Ohio; The Cleveland Clinic Department of Cardiology, Cleveland, Ohio; Parke-Davis Pharmaceutical."Pharmacotherapy for Hyponatremia in Heart Failure: Effects of a New Dual V1a / V2 Vasopressin Antagonist YM087" . : I-299
January 2000 Yamani MH, Kelly L, Albert N, Nance M, Young JB,Haas GJ.."Comparison between dobutamine and milrinone based therapy for acute exacerbation of congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic cost" . : 78
January 2003 Thatipelli M, Armentano DS, Chumita R, Haas GJ."Normal BNP? A marker of LV Recovery" .
January 2004 Nicholson D, Haas GJ, Carnes CA, Abraham WT, Feldman DS."Lack of Efficacy of N-Acetylcysteine in Henuating Contrast-induced nephropathy in patients with severe systolic HF" . : S131
January 2005 Iyengar S, Haas G, Lamba S, Orsinelli D, Babu G, Ferkerich A, Yamokoski L, Periasany M, Abraham W."Effect of Cardiac Resychronozation Therapy ON Myocardial Gene Expression in Patients with Non-Ischemic Dilated Cardiomyopathy." . : 597
January 2005 Abraham WT, Foreman B, Fishel R, Haas G, Moe B.."Fluid Accumulation Status Trial (FAST)" . : S66
January 2005 Doshi A, Wu G, Haas GJ."Pheochromocytoma – induced myocardial shinning presenting as cardiogenic shock" .
January 2007 Ritzema-Carte J, Troughton R, Melton L, Doughty R, Stewart J, Krum H, Whiting J, Eigler N, Haas G, Abraham WT."Accurate non-invasive calibration of an implantable left atrial pressure monitoring system in heart failure patients during long-term follow-up" . : 95A
January 2011 Cowart D, Aranda J, Haas GJ, Neutel J, Smith W, Mazhari R, Kalish V, Colucci W."A Phase I/IIa first in man safety and tolerability study of a novel HNO donor, CXL-10220, in patients with stable congestive heart failure" .

Presentations

Functional and morphological characteristics of a genetically determined heart failure rat model.

When to pursue myocardial biopsy, and the evolving role of cardiac transplantation.

Plasma endothelin is increased in patients following successful cardiac transplantation

Thoracic Transplantation

Evaluation and management of patients awaiting heart transplantation

Chronic Hydralazine or Enalapril mormalize Mysosin ioforms in the sontaneously hypertensive rat, but only Enalalpril normalizes left ventricular mass

Management of severe congestive Heart Failure

Hydralazine or Enalapril Myosin isoforms in the spontaneously hypertensive rat, but only Enalapril normalizes left ventricular mass

Digoxin in heart failure: 200 years of controversy: renewed or resolved

An old paradigm for heart failure therapy: Digoxin

Inotropic therapy in heart failure

Simplified assessment of pulmonary hypertension in heart transplant candidates.

Heart failure therapeutics: challenge of rational polypharmacy

Heart failure therapeutics: challenge of rational polypharmacy

Treatment of advanced heart failure.

Transplantation and other surgical options for advance heart failure

Newer therapeutic approaches in cardiovascular disease

Echocardiographic characterization of LVH in hypertensive animal models

Pathophysiology of Congestive Heart Failure

A clinicians's perspective on polypharmacology for congestive heart failure

Role of endomyocardial biopsy in heart failure

Use of beta-blockade in congestive heart failure patients

Role of beta-blocker therapy in congestive heart failure

Heart failure therapeutics: challenge of rational polypharmacy

Evaluation and management of advance heart failure

Diagnosis and management of heart failure

Case Presentations

Angiostensin Receptor and Beta Adrenergic Blockers in Heart Failure: Perspectives on Emerging Data

Dosing and Initiation of Beta Blockade in Congestive Heart Failure

Review of ISHLT data

Management of the Post Heart Transplant Patient

Pathophysiology of Congestive Heart Failure

Adverse Drug Events in Elderly CHF Patients

Management of Post Heart Transplant Patients

Complications following cardiac transplantation

Evaluation of Congestive Heart failure

Acute Myocarditis

Evaluation and management of acute heart failure

Management of Chronic Heart Failure

Update on BNP

Management of Acute Heart Failure

Management of Heart Failure: Focus on Beta Blockade

Cardiac Resynchronization

Management of Acute Heart Failure

Heart Failure and Cardiac Transplantation

Differences Among Beta Blockers in HF: Focus on COMET

Differences Among Beta Blockers in HF: Focus on COMET

PAH: Right Heart Screening/Diagnostics

Heart Failure Treatment Options 2004

Champ: New Insights in the Treatment of Post MI LVD and HF

Optimizing Drug and Device Therapies in the Management of Left Ventricular Dysfunction

Treatments Options 2004. Management of Heart Failure

Management of Hypertension and Hyperlipidema: Update on Recent Guidelines

A Case-Directed Approach to the Management of the Patient at High-Risk for Cardiovascular Events

Heart Failure Decompensation: The Role of BNP

What's New for the Evaluation and Management of Heart Failure

Promoting CVM Heart Failure Clinical Trials to regional Physicians

Optimizing Drug and Device Therapies in the Management of Left Ventricular Dysfunction

Heart Failure Decompensation: The Role of BNP

Treatment Options 2004: Management of HF

Beta Blocker Therapy in HF

Management of the Diabetic Hypertensive Patient

Optimum Treatment for Decompensated Heart Failure

New Medical Therapies for Heart Failure

Management of the Diabetic Hypertensive Patinet: Impact of the GEMINI Trial/New Insights in the Treatment of Post-MI LVD and HF

Acute Heart Failure Management

Monitoring Heart Failure with Implantable Devices

Pulmonary Hypertension and LV Dysfunction

Acute Heart Failure Management

Emerging Role of Medical Devices for Acute Decompensation Heart Failure

Monitoring Congestion in Heart Failure

The Challenge of Heart Failure Therapy: So many drugs, so little blood pressure

Selection and Treatment of Heart Transplant Candidates

New HF Guidelines: Where we are in the Transplantation of Acute Heart Failure

Role of Natrecor In the Transplantation of Decompensated HF

Treatment Strategies for Acute Decompensation Heart Failure

Use of Ultrafiltration in the management of ADHF

Updates in Treatment of Acute Decompensated Heart Failure

Updates in the Treatment of Acute Decompensated Heart Failure

Management of Acute Decompensation Heart Failure

Treatment Update for acute decompensation heart failure patients

Management of blood pressure in the refactory patient

Monitoring congestion in heart failure.

Acute Heart Failure Management with Nesiritide

Pharmacologic Management Strategies for Heart Failure

Getting started in clinical research

What is Diastolic Dysfunction and Heart Failure

Ultra Filitration

Treatment Stategies in Normal and Reduce EF

Developing a Heart Failure Disease Management Program

Cardiorenal Syndrome

Cardiorenal Syndrome

Pharmacologic management strategies for chronic Heart Failure

Congestive Heart Failure and Cardiogenic Shock

Indications for Devices (Pacemakers and Defibrillators) in congestive heart Failure

Heart failure and the cardio-renal syndrome

Management of Heart Failure

Heart Failure - Healthy at Home

Ultrafiltration in Treatment of Acute Decompensated Heart Failure: Aquaphersis

Ultrafiltration in the Treatment of Acute Decompensated Heart Failure

Managing Volume Overload in Decompensated Heart Failure

Heart Failure Device - Based Updates

Early Recognition and Treatment of Heart Failure; What Have We Learned From Recent Trial?

Caring for Your CHF Patient in the Field: Overview, Changes, Contraversies, What’sNew, What Works

Early Recognition & treatment of Heart Failure - What Have We Learned from Recent Trials

M & M Conference and The Use of Eplerenone

New Approaches on Inpatient Management

Diuretic Strategies for CHF

Management of chronic renal failure.

REVERSAL OF MYOCARDIAL HYPERTROPHY WITH ACE INHIBITION IN A RODENT MODEL OF HEART-FAILURE

 

Professional Activities

2003 - present National Clinical Trail Committee. CEC Medtronic.
2010 - present Heart Failure at the Shoe. The Ohio State University Medical Center. Columbus, OH.
2010 Cardio Outpatient Clincal Patient Based Rotation.